True Blue Savings Program FAQs

Frequently-Asked Questions About the True Blue Savings Program

  • What is the Mitigare® True Blue Savings Program?

    The True Blue Savings Program helps qualified patients save money on their Mitigare® or Generic Colchicine 0.6 mg Capsules prescriptions. With the Mitigare® True Blue Savings Co-pay Card, eligible patients can receive Mitigare® or Generic Colchicine Capsules for as little as $0 for the first 30 days and pay no more than $5 on refills.* See the complete Terms & Conditions and eligibility requirements for the True Blue Savings Program and learn more about Additional Services available.

  • How can I get a Mitigare® True Blue Savings Card?

    Eligible patients* can get a Mitigare® Savings Card in one of two ways:

    • Request information about the program from the doctor,
    • Visit mitigare.com and click on “Download Your Card”

    *For all eligible patients 18 years or older who are legal residents of the United States or Puerto Rico. First 30 days are as little as $0 only for eligible patients. Maximum savings of $65 on the first fill and $50 on refills. Please see complete Terms and Conditions.

  • What additional services are available with the True Blue Savings Program?

    In addition to saving money on Mitigare® and Generic Colchicine Capsules, the True Blue Savings Program offers patients these additional services:

    • Find a Pharmacy Service
    • Access to Savings Offers and Product Information
    • Educational Materials

    Learn more about these Additional Services.

  • Who is eligible for the Mitigare® True Blue Savings Card?

    Patients 18 years or older who are legal residents of the United States or Puerto Rico and are not enrolled in any state or federally funded healthcare program including, but not limited to, Medicare, Medicare Part D, Medicaid (including Medicaid managed care), Medigap, VA, FEHB, DOD, TRICARE, or a state pharmacy assistance program. Please see complete Terms and Conditions.

  • How do I receive the benefits of the program?

    Present the Mitigare® Savings Card to the pharmacist, along with a valid Mitigare® or Authorized Generic Colchicine 0.6 mg Capsules prescription.

  • What if my pharmacy is unable to process my Mitigare® True Blue Savings Card?

    Please mail a copy of your pharmacy receipt indicating Mitigare® or Authorized Generic Colchicine 0.6 mg Capsules and the amount paid to: Mitigare Savings Program; PO Box 42638; Cincinnati, OH 45242. Please allow up to 8 weeks for processing.

  • How do I activate my Mitigare® True Blue Savings Card?

    Activate your card online here, or you can call 1-877-259-6893.

  • Is the Mitigare® True Blue Savings Card transferable?

    No.

  • How long can I use my Mitigare® True Blue Savings Card?

    You may continue to use your card for as long as you are eligible or until this program is terminated. Use your card before the expiration date printed on the front of the card. (Limit one card per patient.) 


Go to All FAQs

Important Safety Information for Mitigare® (colchicine) 0.6 mg capsules

  • Colchicine 0.6 mg capsules are contraindicated in patients with renal or hepatic impairment who are currently prescribed drugs that inhibit both P-gp and CYP3A4. Combining these dual inhibitors with colchicine in patients with renal or hepatic impairment has resulted in life-threatening or fatal colchicine toxicity. Patients with both renal and hepatic impairment should not be given Mitigare®.
  • Fatal overdoses have been reported with colchicine in adults and children. Keep Mitigare® out of the reach of children.
  • Blood dyscrasias such as myelosuppression, leukopenia, granulocytopenia, thrombocytopenia, and aplastic anemia have been reported with colchicine used in therapeutic doses.
  • Monitor for toxicity and if present consider temporary interruption or discontinuation of colchicine.
  • Drug interaction with dual P-gp and CYP3A4 inhibitors: Co-administration of colchicine with dual P-gp and CYP3A4 inhibitors has resulted in life-threatening interactions and death.
  • Neuromuscular toxicity and rhabdomyolysis may occur with chronic treatment with colchicine in therapeutic doses, especially in combination with other drugs known to cause this effect. Patients with impaired renal function and elderly patients (including those with normal renal and hepatic function) are at increased risk. Consider temporary interruption or discontinuation of Mitigare®.
  • The most commonly reported adverse reactions with colchicine are gastrointestinal symptoms, including diarrhea, nausea, vomiting, and abdominal pain.

Indication

Mitigare® is indicated for prophylaxis of gout flares in adults. The safety and effectiveness of Mitigare for acute treatment of gout flares during prophylaxis has not been studied.

Mitigare® is not an analgesic medication and should not be used to treat pain from other causes.

For Full Prescribing Information please CLICK HERE and for Medication Guide CLICK HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228

Read More...

Important Safety Information for Mitigare® (colchicine) 0.6 mg capsules

  • Colchicine 0.6 mg capsules are contraindicated in patients with renal or hepatic impairment who are currently prescribed drugs that inhibit both P-gp and CYP3A4.